IMGM Laboratories, a genomic service provider based in Martinsried/Munich, Germany, uses Roche 454 next-generation sequencing systems and their highly experienced sequencing and bioinformatics staff to provide expert metagenomics services, with a focus on 16S rRNA sequencing. IMGM Laboratories announced today the availability of extra-long read 16S amplicon sequencing services using the latest GS FLX+ system […]
Menlo Park, CA – Personalis today announced the appointment of Adam Lowe as Vice President of Marketing. Mr. Lowe’s extensive experience building commercial and scientific teams in the genomics field will be critical in driving the company’s product and commercialization strategies. Mr. Lowe brings over 20 years of life science experience in marketing, product development, […]
MOUNTAIN VIEW, Calif. –– Complete Genomics, Inc. (formerly NASDAQ: GNOM) (“Complete”), a wholly-owned subsidiary of BGI-Shenzhen (“BGI”), a leading international genomics organization based in Shenzhen, China, today announced that it has entered into a settlement agreement with Illumina, Inc. under which Illumina will dismiss with prejudice both lawsuits it had brought against Complete: Illumina, Inc. […]
SAN DIEGO — Illumina, Inc. (NASDAQ:ILMN) today announced the availability of its Phasing Analysis Service, provided by the company’s FastTrack Services lab through the Illumina Genome Network (IGN). The new sample-to-answer service delivers human whole-genome phase information, empowering gene mapping studies with a more comprehensive view of genomic variation. With phase data, researchers can better […]
MENLO PARK, Calif., — Pacific Biosciences of California, Inc. (Nasdaq:PACB), provider of the PacBio® RS II DNA Sequencing System, today announced that John F. Milligan, Ph.D. has joined the Company’s Board of Directors. Dr. Milligan currently serves as President and Chief Operating Officer of Gilead Sciences. Dr. Milligan joined Gilead Sciences in 1990 as a […]
BOSTON –– Pathogenica Inc. announced today it had entered into an agreement with Illumina(NASDAQ:ILMN), whereby the parties will co-market in the Asia Pacific region a new version of Pathogenica’s HAI BioDetection kit compatible with Illumina’s MiSeq benchtop sequencing system. The combined solution will enable users to identify an expanded panel of bacteria and drug resistance […]
Pathogenica, Inc. announced that teams from the University Medical Center Groningen (UMCG) and Amphia Hospital in the Netherlands are pioneering the use of the company’s HAI BioDetection Kit to prevent and control nosocomial infections in their facilities. With approx. 1,400 beds each, both Amphia and UMCG are among the largest hospitals in the world. Pathogenica’s […]
RICHMOND, VA — AIBioTech has reached the milestone of 20,000 DNA samples sequenced on its Ion Torrent Personal Genome Machines™ (PGMÔ) by Life Technologies. As an early adapter of this cutting edge technology, AIBioTech is one of the first companies to apply the Life Technologies Ion Torrent sequencing technology to the CLIA laboratory market place. […]
Hitachi High-Technologies Corporation (TOKYO: 8036, Hitachi High-Tech), a cutting-edge technology company developing and manufacturing scientific and medical systems and Base4 Innovation Ltd. (Base4), the privately-owned Cambridge-based DNA sequencing company today announce that they have entered into a collaborative technology development agreement to develop a long read-length, single-molecule, nanopore-based DNA sequencing system. The system will be […]
SAN DIEGO and NEW YORK, — BioNano Genomics and the New York Genome Center (NYGC) announced today a strategic partnership between the two institutions that includes the purchase of an Irys™ System by NYGC. “The New York Genome Center is creating one of the largest and most ambitious genomics and bioinformatics facilities in North America, […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
